What's in Value Outcomes Ltd.'s pipeline?

Value Outcomes Ltd. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Value Outcomes Ltd.'s portfolio?

Top competitors by shared drug class: Assiut University, Barbara Ann Karmanos Cancer Institute, Center for Human Reproduction, Guna spa, Newton Laboratories, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/value-outcomes-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Value Outcomes Ltd. — Portfolio Competitive Intelligence Brief

Value Outcomes Ltd. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Vessel	Vessel	marketed	Standardized Insect Venom Allergenic Extract [EPC]		Other

Therapeutic area mix

Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assiut University · 1 shared drug class
Barbara Ann Karmanos Cancer Institute · 1 shared drug class
Center for Human Reproduction · 1 shared drug class
Guna spa · 1 shared drug class
Newton Laboratories, Inc. · 1 shared drug class
Suez Canal University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Value Outcomes Ltd.:

Cite this brief

Drug Landscape (2026). Value Outcomes Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/value-outcomes-ltd. Accessed 2026-05-14.